MedPath

Polyethylene glycol

Generic Name
Polyethylene glycol
Brand Names
Bi-peglyte, Clearlax, Colyte, Gavilax, Gavilyte-C, Gavilyte-G, Gavilyte-H and Bisacodyl, Gavilyte-N, Gentlelax, Gialax, Glycolax, Golytely, Healthylax, Miralax, Moviprep, Nulytely, Peglyte, Pegylax, Plenvu, Purelax, Suflave
Drug Type
Small Molecule
CAS Number
25322-68-3
Unique Ingredient Identifier
3WJQ0SDW1A
Background

Polyethylene glycol (PEG) is a synthetic polymer produced via polymerization of ethylene oxide molecules to make joining units of ethylene glycol by an ether linkage. PEGs are water-soluble polymers that can form hydrogen bonds in a ratio of 100 water molecules per one PEG molecule. Molecular weights of PEGs vary by time of the polymerization process and the molecular weight represents the weighted average of the individual PEG molecules. PEGs differ in their physical and chemical properties depending on their molecular weight: PEGs are liquids when molecular weights are <1000 and the molecule turns to waxy solids with increasing molecular weights. The most common preparations of PEGs include PEG 3350 and PEG 400. PEGs have various applications in many fields, ranging from medical to industrial areas. PEGs have a long history of gastroenterology: PEG 3350 is a common over-the-counter osmotic laxative used to relieve occasional constipation. PEG 3350 is also used for cleansing of the colon in preparation for colonoscopy in adults.

The rationale of using PEG in gastroenterology is due to the physical properties of the compound: its potent water-binding capacity, negligible intestinal absorption with increasing molecular mass, lack of significant toxicity, and limited intestinal enzymatic degradation or bacterial metabolism all make PEG a useful therapeutic agent for the treatment of occasional constipation and bowel cleansing for preparation in colonoscopy.

Indication

Polyethylene glycol is indicated for use as an over-the-counter osmotic laxative to relieve occasional constipation. When used in combination with sodium ascorbate, sodium sulfate, ascorbic acid, sodium chloride and potassium chloride, it is used for cleansing of the colon in preparation for colonoscopy in adults.

Associated Conditions
Chronic Constipation, Constipation, Dry Eye Syndrome (DES), Dry Eyes, Occasional Constipation
Associated Therapies
Bowel preparation therapy, Eye lubrication

Efficacy of Polyethylene Glycol vs Lactulose With Isabgol in Acute Fissure-in-Ano: PEGASIS Trial

Phase 2
Completed
Conditions
Anal Fissure
Constipation
Interventions
First Posted Date
2022-04-22
Last Posted Date
2023-07-25
Lead Sponsor
All India Institute of Medical Sciences, Bhubaneswar
Target Recruit Count
144
Registration Number
NCT05341180
Locations
🇮🇳

All India Institute of Medical Sciences, Bhubaneswar, Odisha, India

Bladder and Bowel Dysfunction in Children

Not Applicable
Recruiting
Conditions
Bladder and Bowel Dysfunction
Interventions
Behavioral: Urotherapy
First Posted Date
2022-04-08
Last Posted Date
2024-05-08
Lead Sponsor
University of Aarhus
Target Recruit Count
100
Registration Number
NCT05318365
Locations
🇩🇰

Goedstrup Regional Hospital, Herning, Denmark

🇩🇰

Aarhus University Hospital, Aarhus, Denmark

🇩🇰

Aalborg University Hospital, Aalborg, Denmark

Application of Linaclotide Capsule in Bowel Preparation for Colonoscopy

Not Applicable
Completed
Conditions
Bowel Preparation for Colonoscopy
Interventions
First Posted Date
2022-03-22
Last Posted Date
2024-06-20
Lead Sponsor
Changhai Hospital
Target Recruit Count
1607
Registration Number
NCT05291325
Locations
🇨🇳

Changhai Hospital, Naval Medical University, Shanghai, China

Prevention of Opioid-induced Constipation in Patients With Advanced Cancer

Phase 4
Recruiting
Conditions
Constipation, Opioid-Induced
Interventions
Drug: Magnesium hydroxide 724mg
First Posted Date
2022-01-31
Last Posted Date
2024-11-22
Lead Sponsor
Amsterdam UMC, location VUmc
Target Recruit Count
330
Registration Number
NCT05216328
Locations
🇳🇱

Spaarne Gasthuis, Hoofddorp, Noord-Holland, Netherlands

🇳🇱

Jeroen Bosch Ziekenhuis, 's Hertogenbosch, Noord-Brabant, Netherlands

🇳🇱

Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands

and more 10 locations

Colon Cleansing Efficacy With 1L vs. 2L vs. 4L-PEG for Colonoscopy Among Inpatients

Phase 4
Conditions
Colon Disease
Interventions
First Posted Date
2021-01-13
Last Posted Date
2021-01-13
Lead Sponsor
University of Bologna
Target Recruit Count
846
Registration Number
NCT04708366
Locations
🇮🇹

Policlinico Sant'Orsola-Malpighi, Bologna, Italy

Comparison of Potassium Binders in the ER

Phase 4
Recruiting
Conditions
Acute Hyperkalemia
Oral Potassium Binders
Interventions
Drug: Sodium Polystyrene Sulfonate Oral Suspension [SPS]
First Posted Date
2020-10-14
Last Posted Date
2024-08-12
Lead Sponsor
University of California, Irvine
Target Recruit Count
120
Registration Number
NCT04585542
Locations
🇺🇸

University of California, Irvine Medical Center, Orange, California, United States

Improved Bowel Preparation Method for Colonoscopy Based on Different Risk Stratification

Not Applicable
Completed
Conditions
Bowel Preparation Before Colonoscopy
Interventions
Drug: PEG+lactulose
First Posted Date
2020-10-12
Last Posted Date
2022-12-20
Lead Sponsor
Renmin Hospital of Wuhan University
Target Recruit Count
2028
Registration Number
NCT04582942
Locations
🇨🇳

Renmin Hospital of Wuhan University, Wuhan, Hubei, China

The Effect of a Predictive Model of Bowel Preparation Based on Procedure-related Factors

Not Applicable
Completed
Conditions
Colonoscopy
Predictive Model
Bowel Preparation
Interventions
First Posted Date
2020-06-17
Last Posted Date
2021-09-14
Lead Sponsor
Air Force Military Medical University, China
Target Recruit Count
900
Registration Number
NCT04434625
Locations
🇨🇳

Department of Gastroenterology, Hongai Hospital, Xiamen, Fujian, China

🇨🇳

Department of Gastroenterology, Huaihe Hospital of Henan University, Kaifeng, Henan, China

🇨🇳

Department of Holistic Integrative Medicine, Shenzhen Hospital of Southern Medical University, Shenzhen, Guangdong, China

and more 2 locations

Polyethylene Glycol to Improve Sensation Following Digital Nerve Laceration

Phase 1
Withdrawn
Conditions
Nerve Injury
Peripheral Nerve Injury
Interventions
First Posted Date
2020-02-17
Last Posted Date
2024-01-05
Lead Sponsor
Nova Scotia Health Authority
Registration Number
NCT04270019

Bowel Function After Minimally Invasive Hysterectomy

Phase 4
Recruiting
Conditions
Constipation
Interventions
First Posted Date
2020-02-11
Last Posted Date
2024-10-30
Lead Sponsor
University of Chicago
Target Recruit Count
101
Registration Number
NCT04263896
Locations
🇺🇸

University of Chicago Medicine, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath